- Home
- HUMAW vs THM Comparison
HUMAW vs THM Comparison
Compare HUMAW & THM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- THM
- Stock Information
- Founded
- HUMAW 2004
- THM 1978
- Country
- HUMAW United States
- THM Canada
- Employees
- HUMAW 220
- THM N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- THM
- Sector
- HUMAW Health Care
- THM
- Exchange
- HUMAW Nasdaq
- THM Nasdaq
- Market Cap
- HUMAW N/A
- THM N/A
- IPO Year
- HUMAW N/A
- THM N/A
- Fundamental
- Price
- HUMAW $0.48
- THM $1.09
- Analyst Decision
- HUMAW
- THM
- Analyst Count
- HUMAW 0
- THM 0
- Target Price
- HUMAW N/A
- THM N/A
- AVG Volume (30 Days)
- HUMAW 14.2K
- THM 308.9K
- Earning Date
- HUMAW 03-21-2025
- THM 08-08-2025
- Dividend Yield
- HUMAW N/A
- THM N/A
- EPS Growth
- HUMAW N/A
- THM N/A
- EPS
- HUMAW N/A
- THM N/A
- Revenue
- HUMAW N/A
- THM N/A
- Revenue This Year
- HUMAW N/A
- THM N/A
- Revenue Next Year
- HUMAW N/A
- THM N/A
- P/E Ratio
- HUMAW N/A
- THM N/A
- Revenue Growth
- HUMAW N/A
- THM N/A
- 52 Week Low
- HUMAW $1.18
- THM $0.40
- 52 Week High
- HUMAW $1.34
- THM $1.10
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- THM 66.69
- Support Level
- HUMAW N/A
- THM $0.84
- Resistance Level
- HUMAW N/A
- THM $0.99
- Average True Range (ATR)
- HUMAW 0.00
- THM 0.06
- MACD
- HUMAW 0.00
- THM 0.01
- Stochastic Oscillator
- HUMAW 0.00
- THM 93.48
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.